Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Am J Surg Pathol. 2010 Mar;34(3):418-22. doi: 10.1097/PAS.0b013e3181ce5066.
Studies predominantly performed on cystectomy specimens have shown that antibodies against smoothelin can distinguish between muscularis mucosae (MM) (negative or weak stain) and muscularis propria (MP) (strong stain). However, studies on diagnostically difficult (transurethral resection) specimens have not been performed. We studied 34 transurethral resection cases where outside pathologists questioned the presence of MP invasion. Upon expert review of the H&E slides, there was no MP invasion in 18 cases. Smoothelin in MM was negative in 8/18 (44%), weakly positive (1+) in 5/18 (28%), moderately positive (2+) in 4/18 (22%), and moderately/strongly (2-3+) positive in 1/18 (6%). Smoothelin in uninvolved MP present in 8 cases was: 2+ in 2/8 (25%) and 3+in 6/8 (75%). Smoothelin expression in MM was weaker than in MP in 7/8 (88%) cases where both were present. Of 16 tumors with MP invasion, smoothelin in involved MP was: 1+ in 1/16 (6%), 2+ in 3/16 (19%), 2 to 3+ in 9/16 (56%), and 3+ in 3/16 (19%). Smoothelin expression in concurrent uninvolved MP was similar. Our data confirm the relatively distinct staining pattern of smoothelin between MM and MP. However, due to the overlap of intensity between MM and MP, caution should be maintained while using smoothelin immunohistochemistry as a diagnostic tool for MP invasion.
研究主要在膀胱全切除标本上进行,结果表明,抗 smoothelin 抗体可区分黏膜肌层(MM)(阴性或弱阳性染色)和固有肌层(MP)(强阳性染色)。然而,尚未对诊断困难(经尿道切除)标本进行研究。我们研究了 34 例经尿道切除病例,外部病理学家对 MP 侵犯的存在提出了质疑。在对 H&E 切片进行专家审查后,18 例中无 MP 侵犯。18 例 MM 中的 smoothelin 阴性 8/18(44%),弱阳性(1+)5/18(28%),中度阳性(2+)4/18(22%),中度/强阳性(2-3+)阳性 1/18(6%)。8 例未受累 MP 中的 smoothelin 为:2+ 2/8(25%)和 3+ 6/8(75%)。7/8(88%)例同时存在 MM 和 MP 时,MM 中的 smoothelin 表达弱于 MP。16 例 MP 侵犯的肿瘤中,受累 MP 中的 smoothelin 为:1+ 1/16(6%),2+ 3/16(19%),2-3+ 9/16(56%),和 3+ 3/16(19%)。同时存在的未受累 MP 中的 smoothelin 表达相似。我们的数据证实了 smoothelin 在 MM 和 MP 之间相对独特的染色模式。然而,由于 MM 和 MP 之间强度的重叠,在使用 smoothelin 免疫组化作为 MP 侵犯的诊断工具时应保持谨慎。